RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Single-cell analyses identify dysfunctional CD16+ CD8 T cells in smokers
Martos, S. N., Campbell, M. R., Lozoya, O. A., Wang, X., Bennett, B. D., Thompson, I. J. B., Wan, M., Pittman, G. S., & Bell, D. A. (2020). Single-cell analyses identify dysfunctional CD16+ CD8 T cells in smokers. Cell Reports Medicine, 1(4), Article 100054. https://doi.org/10.1016/j.xcrm.2020.100054
Tobacco smoke exposure contributes to the global burden of communicable and chronic diseases. To identify the immune cells affected by smoking, we use single-cell RNA sequencing on peripheral blood from smokers and nonsmokers. Transcriptomes reveal a subpopulation of FCGR3A (CD16)-expressing natural killer (NK)-like CD8 T lymphocytes that increase in smokers. Mass cytometry confirms elevated CD16(+) CD8 T cells in smokers. Inferred as highly differentiated by pseudotime analysis, NK-like CD8 T cells express markers that are characteristic of effector memory re-expressing CD45RA T (T-EMRA) cells. Indicative of immune aging, smokers' CD8 T cells are biased toward differentiated cells, and smokers have fewer naive cells than nonsmokers. DNA methylation-based models show that smoking dose is associated with accelerated aging and decreased telomere length, a biomarker of T cell senescence. Immune aging accompanies T cell senescence, which can ultimately lead to impaired immune function. This suggests a role for smoking-induced, senescence-associated immune dysregulation in smoking-mediated pathologies.